Concepedia

Author

Nikolaus Schicher

Medical University of Vienna

Also Known As

N. Schicher, Nikolaus Schicher

17

Publications

344

Citations

8

H-Index

19

Concepts

All Affiliations

Medical University of ViennaUniversity of Vienna
NS

About

Nikolaus Schicher is an author at Medical University of Vienna specializing in medicine, tumor biology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

112

2

Cell Biology

2

2

77

3

Immunology

1

1

21

4

Otolaryngology

1

1

21

5

Pathology

1

1

14

Nikolaus Schicher

×

8

Publications

333

Citations

8

H-Index

YearCitations

Erlotinib and Bevacizumab Have Synergistic Activity against Melanoma

Nikolaus Schicher, Verena Paulitschke, Alexander Swoboda,

Clinical Cancer Research

2009

85

The interplay of CDK4 and CDK6 in melanoma

Karoline Kollmann, Coralie Briand, Florian Bellutti,

Oncotarget

2019

65

The Non-Receptor-Associated Tyrosine Kinase Syk is a Regulator of Metastatic Behavior in Human Melanoma Cells

Christoph Höeller, Christiane Thallinger, Barbara Pratscher,

Journal of Investigative Dermatology

2005

47

Fotemustine Chemoembolization of Hepatic Metastases From Uveal Melanoma: A Retrospective Single-Center Analysis

Gundula Edelhauser, Nikolaus Schicher, Dominik Berzaczy,

American Journal of Roentgenology

2012

38

Proteome Analysis Identified the PPARγ Ligand 15d-PGJ2 as a Novel Drug Inhibiting Melanoma Progression and Interfering with Tumor-Stroma Interaction

Verena Paulitschke, Silke Gruber, Elisabeth Hofstätter,

PLoS ONE

2012

33

3,3′,4,4′,5,5′-Hexahydroxystilbene Impairs Melanoma Progression in a Metastatic Mouse Model

Verena Paulitschke, Nikolaus Schicher, Thomas Szekeres,

Journal of Investigative Dermatology

2009

30

Successful Treatment of Poststreptococcal Scleredema Adultorum Buschke With Intravenous Immunoglobulins

Maximilian C. Aichelburg, Robert Loewe, Nikolaus Schicher,

Archives of Dermatology

2012

21

A rare case of primary rhabdoid melanoma of the urinary bladder treated with ipilimumab, an anti-CTLA 4 monoclonal antibody

Katja Schindler, Nikolaus Schicher, Rainer Kunstfeld,

Melanoma Research

2012

14

Page 1